Filed: 11/14/2025ACC: 0001193125-25-282923
📋 What this filing means
COLUMN GROUP LLC filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $80.96M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$80.96M
Total AUM (reported)
14.61M
Total Shares
Allocation by class
COM$80.96M100.0%
Portfolio Concentration
Top 3$76.67M94.7%
4–10$4.29M5.3%
Top 3 weight
94.7%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 14.61M
Sole
Full voting authority
14.61M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
ORIC Pharmaceuticals Inc.
SOLEShares3.54M
TypeSH
Market value$42.49M
52.48%
Sole
3.54M
Shared
0.00
None
0.00
Surrozen, Inc.
SOLEShares1.50M
TypeSH
Market value$19.33M
23.88%
Sole
1.50M
Shared
0.00
None
0.00
Tenaya Therapeutics, Inc.
SOLEShares9.40M
TypeSH
Market value$14.85M
18.35%
Sole
9.40M
Shared
0.00
None
0.00
RAPT Therapeutics Inc
SOLEShares166.07K
TypeSH
Market value$4.28M
5.29%
Sole
166.07K
Shared
0.00
None
0.00
Revolution Medicines Inc
SOLEShares46.00
TypeSH
Market value$2.1K
<0.01%
Sole
46.00
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ORIC Pharmaceuticals Inc.SOLE | COM | 3.54M | SH | $42.49M 52.48% | 3.54M | 0.00 | 0.00 |
Surrozen, Inc.SOLE | COM | 1.50M | SH | $19.33M 23.88% | 1.50M | 0.00 | 0.00 |
Tenaya Therapeutics, Inc.SOLE | COM | 9.40M | SH | $14.85M 18.35% | 9.40M | 0.00 | 0.00 |
RAPT Therapeutics IncSOLE | COM | 166.07K | SH | $4.28M 5.29% | 166.07K | 0.00 | 0.00 |
Revolution Medicines IncSOLE | COM | 46.00 | SH | $2.1K <0.01% | 46.00 | 0.00 | 0.00 |